Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients

This study has been completed.

Study NCT00034255 Information provided by GMP Endotherapeutics

First Received: April 24, 2002 Last Updated: June 23, 2005 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given